About
Hayden IR
About Us
Time is valuable. Our mission is to make investor relations efficient and effective by focusing on increasing visibility and creating comprehensive investment stories.{ See our Services }
Our method is designed to improve the quality and quantity of our clients’ investor interactions, and to assure that communications with investors tell a comprehensive, compelling, and distinct story.
{ Review Our Results }
Latest News
September 10, 2025
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
{ Read More }
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
{ Read More }
September 4, 2025
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology
{ Read More }
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology
{ Read More }
September 4, 2025
Safe Pro’s Airborne Response Awarded Two New Disaster Response Contracts for Drone-Based Aerial Imagery Services
{ Read More }
Safe Pro’s Airborne Response Awarded Two New Disaster Response Contracts for Drone-Based Aerial Imagery Services
{ Read More }
Events
H.C. Wainwright 27th Annual Global Investment Conference
September 8-10, 2025 Lotte New York – Palace Hotel
{ Learn More }
September 8-10, 2025 Lotte New York – Palace Hotel
{ Learn More }